MHRA recalls five batches of bimatoprost eye drops
The MHRA has recalled five batches of Bimatoprost Aspire eye drops, with pharmacies required to stop dispensing affected supplies.
The watchdog issued a class 3 medicines recall for five batches of Bimatoprost Aspire 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 earlier today. This precautionary measure is being taken “due to the identification of some variability in the thickness of plastic of the single dose containers,” which has made it difficult for some patients to squeeze the solution from the container.
Healthcare professionals are advised to stop supplying the affected batches immediately and to quarantine all remaining stock before returning it to their supplier.
Get back to basics on the causes and impact of erection problems so you can confidently support your male customers
Viatris has created this short video based on a publication reviewing global research into the potential impact of the Covid-19 pandemic on mental health. It identifies six areas where psychiatrists can play a role in supporting people's mental health through these difficult times.